FTAI is up +138.36% since Oct ’23 pick Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.01 $12.01 Monday, 26th Feb 2024 AGLE stock ended at $12.01. During the day the stock fluctuated 0% from a day low at $12.01 to a day high of $12.01.
90 days $12.01 $12.01
52 weeks $2.65 $24.00

Historical Aeglea BioTherapeutics prices

Date Open High Low Close Volume
Feb 06, 2017 $4.11 $4.38 $4.05 $4.29 115 525
Feb 03, 2017 $4.10 $4.10 $4.02 $4.02 16 932
Feb 02, 2017 $4.10 $4.11 $3.97 $4.09 14 598
Feb 01, 2017 $4.01 $4.10 $3.83 $4.09 46 753
Jan 31, 2017 $4.08 $4.23 $3.66 $3.99 71 942
Jan 30, 2017 $4.06 $4.39 $4.00 $4.01 77 875
Jan 27, 2017 $4.20 $4.41 $4.00 $4.02 183 559
Jan 26, 2017 $4.20 $4.21 $4.02 $4.10 50 353
Jan 25, 2017 $4.82 $4.99 $4.20 $4.21 31 420
Jan 24, 2017 $4.58 $4.58 $4.38 $4.38 35 345
Jan 23, 2017 $4.74 $5.00 $4.35 $4.62 86 471
Jan 20, 2017 $4.90 $4.90 $4.60 $4.61 13 124
Jan 19, 2017 $5.17 $5.24 $4.86 $4.89 13 562
Jan 18, 2017 $5.15 $5.25 $5.15 $5.18 19 213
Jan 17, 2017 $5.25 $5.30 $5.07 $5.07 9 485
Jan 13, 2017 $5.11 $5.37 $5.05 $5.19 17 873
Jan 12, 2017 $5.29 $5.35 $5.15 $5.18 2 739
Jan 11, 2017 $5.08 $5.39 $5.03 $5.33 8 390
Jan 10, 2017 $5.11 $5.30 $5.01 $5.01 9 652
Jan 09, 2017 $5.11 $5.32 $5.06 $5.21 9 532
Jan 06, 2017 $5.29 $5.40 $4.79 $5.26 12 889
Jan 05, 2017 $5.00 $5.20 $4.71 $4.94 13 235
Jan 04, 2017 $4.62 $5.24 $4.57 $4.99 23 197
Jan 03, 2017 $4.36 $4.73 $4.36 $4.57 15 025
Dec 30, 2016 $4.51 $4.63 $4.27 $4.35 50 802

FAQ

What are historical stock prices?
Historical stock prices refer to a stock’s recorded prices at various past points. These prices include several key figures that help investors and analysts evaluate a stock’s performance over time:
Open: Open price for the trading day.
High: Highest price for the trading day.
Low: Lowest price for the trading day.
Close: Close price for the trading day.

Additionally, historical prices often include:
Volume is the number of shares traded during the day. It indicates how actively a stock was traded and can provide insights into market sentiment and liquidity.

How can I use AGLE stock historical prices to predict future price movements?
Trend Analysis: Examine the AGLE stock’s historical trends to identify patterns that might continue.
Moving Averages: Use moving averages to detect potential reversal points.
Momentum Indicators: Apply indicators like RSI or MACD to assess the momentum and strength of price movements.
Volume Analysis: Analyze trading volume alongside price changes to gauge trend strength.
Statistical Methods: Use statistical tools such as regression analysis to model and forecast future prices based on past data.
These techniques can provide insights but should be used with risk management practices to mitigate potential losses.

What impact do stock splits have on historical price data?
When a company performs a stock split, it adjusts the historical price data to reflect the new, lower trading price as if it had always been that way.

This ensures consistency for anyone analyzing the stock’s past prices. The adjustment helps prevent misleading signals on charts, such as false sell signals or bearish trends that aren’t there. For instance, in a 2-for-1 stock split, the price per share is cut in half, which would otherwise appear as a dramatic drop on the chart. If someone didn’t know about the split, they might wrongly think something negative happened to the company. Most technical indicators would also react to this apparent drop by signaling to sell.

A stock split, while making the shares seem more affordable and potentially more attractive to investors, doesn’t alter the company’s fundamental value.

Why do the AGLE stock historical prices show a range for periods like 30 days, 90 days, and 52 weeks?
The range provides the lowest and highest prices at which the stock has traded during the specified period. This helps investors understand the stock’s volatility and price variability within that timeframe.

How can I use historical price volatility to assess risk?
High price volatility historically indicates higher risk and potentially higher returns. Investors can gauge the stock’s risk level by examining the range between high and low prices over various periods.
Click to get the best stock tips daily for free!

About Aeglea BioTherapeutics

Aeglea BioTherapeutics Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, w... AGLE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT